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ABSTRACT 
Electron  microscope studies  were carried  out  with  the  adrenocortical carcinoma 
494 and normal adrenal cortex tissue. The mitochondria of the tumor cells showed 
marked differences when compared with mitochondria from fasciculata cells of the 
normal adrenal cortex. These differences were primarily related to mitochondrial 
number and crista structure. 
Corticosterone production in isolated tumor cells was extremely low and neither 
ACTH nor dibutyryl cyclic AMP had any stimulatory effect. Normal adrenal cells 
showed  at  least  a  tenfold  increase  under  identical  conditions.  In the  presence of 
corticosteroid precursors the amount of corticosterone produced by the tumor cells 
was much less than that produced  by normal cells. 
The  results  indicate  a  reduced  capacity,for  l l~-hydroxylation  in  the  tumor 
mitochondria  and  a  possible  reduced  capacity  for  biosynthetic  steps  before  the 
1 l~-hydroxylation reaction. Glycolysis in isolated tumor cells was also lower than 
in normal cells. 
Isolated tumor mitochondria oxidized succinate normally with a good degree of 
coupling with phosphorylation. However, unlike normal adrenal mitochondria, the 
tumor  mitochondria  showed  little  or  no  oxygen  uptake  with  other  Krebs  cycle 
substrates.  These data suggest that the tumor mitochondria may be lacking in the 
flavoprotein  dehydrogenases  responsible  for  the  oxidation  of  NADH  and 
NADPH,  although  other components of the respiratory chain may be intact. 
INTRODUCTION 
The adrenocortical carcinoma 494,  originally dis- 
covered in  the  rat by Snell  and  Stewart (l),  has 
been  studied  by  several  laboratories  (2-7)  to 
determine  its  steroid  biosynthetic  potential  and 
compare it with that in the normal adrenal. Ney et 
al.  (3)  noted  that  the  tumor  was  able  to  utilize 
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tion.  However,  the  rate  of  synthesis  was  greatly 
reduced  (2,  3).  This  was  especially  true  of  the 
1 l/3-hydroxylation  of  1 l-deoxycorticosterone 
(DOC) 1 to corticosterone (2). 
The effect of adrenocorticotropin  (ACTH)  and 
adenosine-Y,5'-monophosphate  (CAMP)  on  the 
tumor has also been studied. Although ACTH was 
unable  to  stimulate  steroidogenesis  in  this  tissue 
(3),  Schorr  et  al.  (4,  6)  demonstrated  that  the 
trophic  hormone  was  capable  of  stimulating  the 
tumor  adenyl  cyclase  to  produce  fairly  large 
amounts  of  CAMP.  The  only  abnormality  ap- 
peared  to be in the lack of specificity for ACTH. 
Unlike  the  adenyl  cyclase  in  the  normal  adrenal 
cortex,  which  is  stimulated  only  by  ACTH,  the 
tumor adenyl cyclase was stimulated by a  number 
of other trophic hormones (e.g.,  thyroid-stimulat- 
ing  hormone,  luteinizing,  and  follicle-stimulating 
hormone).  From these results and the finding that 
large concentrations of exogenous CAM P failed to 
stimulate corticosteroidogenesis in vitro (3), it was 
concluded  that  reduced  steroidogenesis  in  the 
tumor was due primarily to a defect(s) beyond the 
formation of CAMP  (4). 
Corticosteroidogenesis  in  the  normal  adrenal 
gland  is  a  process  dependent  on  several  steps. 
Fractionation  studies  showed  some  of  these  to 
occur  in  the mitochondrial fraction and  others to 
occur in the microsomal fraction (8, 9). Therefore, 
it is possible that the reduced rate of steroidogene- 
sis  in  the  tumor  may  be a  result  of a  defect(s) in 
one  or  more  of  the  cell  organelles.  The  present 
study was designed to correlate the ultrastructure 
of  the  rat  adrenocortical  carcinoma  494  with  its 
corticosteroidogenic  potential  and  to  make  an 
overall  comparison  with  the  normal  rat  adrenal 
cortex.  The findings of an alteration in the tumor 
mitochondrial structure and the biosynthetic steps 
associated with it give evidence that the abnormal 
steroidogenesis of the tumor can be largely attrib- 
uted to abnormal mitochondrial function. In addi- 
tion,  our  results  demonstrate  a  lowered  capacity 
for specific mitochondrial oxidations in the tumor 
which suggest a  possible lack of certain enzymes in 
the respiratory chain. 
1  The generic names of substances for which trivial names 
have  been  given  in  the  paper  are:  Pregnenolone,  313- 
hydroxy-5-pregnene-20-one;  progesterone,  4-preg- 
nene-3,20-dione;  DOC,  11-deoxycorticosterone,  21- 
hydroxy-4-pregnene-3,20-dione; corticosterone, 11B,21- 
dihydroxy-4-pregnene-3,20-dione;  1 l~-OH-progester- 
one,  11B-hydroxy-4-pregnene-3,20-dione. 
MATERIALS  AND  METHODS 
Animals 
The  rat  adrenocortical  carcinoma  494  was  trans- 
planted  and  maintained  in  a  manner  similar  to  that 
described by Ney et al. (3). Young male Sprague-Dawley 
rats  (Charles  River  Breeding  Laboratories,  inc.,  Wil- 
mington,  Mass.),  weighing 50-70 g,  received viable tu- 
mor tissue subcutaneously through a small incision near 
the base of the tail. The tumor tissue for all studies was 
taken 4-6 wk  after the initial transplant. The atrophic 
adrenals from  the tumor-bearing animal were  also  re- 
moved at this time.  Normal male rats of the same age 
were used as a  source for normal adrenal tissue. Adre- 
nal tissue was also taken for electron microscope exami- 
nation from tumor-bearing and control rats which had 
received  long-term  ACTH  treatment.  Treatment  con- 
sisted to  three daily subcutaneous injections (morning, 
noon, and evening) of ACTH  (Acthar gel,  40 USP U/ 
ml,  Armour  Pharmaceutical Co.,  Chicago,  ILL), for  a 
2-wk period. 
Preparation  of Tissue for 
Electron  Microscopy 
Tissues  for  ultrastructural  studies  were  fixed  in  5% 
glutaraldehyde  (pH  7.2)  for 2 h  at room  temperature. 
This was followed by postfixation in 2% OsO4 (pH 7.2) 
for 1.5 h. Both fixatives were made in 0.1 M  PO4 buffer 
containing CaC12. Samples  were  then dehydrated  in a 
graded series of aqueous ethanol solutions and embedded 
in  Epon  812  by  the  method  of  Luft  (10).  Ultrathin 
sections  were  cut  on  a  Porter-Blum  MT2-B  ultrami- 
crotome  (Ivan  Sorvall,  Inc.,  Newtown,  Conn.),  and 
stained  with  uranyl  acetate  and  lead  citrate.  Sections 
were viewed  with a Zeiss EM9S-2 electron microscope. 
Cell Preparation and Incubations 
Cells  were  isolated  from  the  normal  adrenal  as 
previously described by this laboratory (11,  12). Isolated 
tumor cells were prepared both with and without the use 
of proteolytic enzymes. Tumor cells were isolated using 
trypsin and collagenase following a  procedure identical 
to that for normal adrenal cell isolation. For tumor ceils 
isolated without enzymes, viable tumor tissue was placed 
in  a  50-ml  erlenmeyer  flask  containing 20  ml  Krebs- 
Ringer bicarbonate buffer plus glucose (KRBG) (11,  12). 
The flask was gassed with 95% 02-5% CO2, and the tissue 
stirred for 15-20 min at 37°C using a  magnetic stirrer. 
This was repeated six to eight times, with fresh KRBG 
each time. The first two fractions were discarded due to a 
large amount of contamination with red blood cells. The 
remaining fractions were then centrifuged and concen- 
trated according to the procedure for normal adrenal cell 
isolation. All isolated cells demonstrated an ultrastruc- 
ture  identical  to  that  of their  respective  intact tissue. 
Similar results have been reported by Sharma et al. (13) 
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(5)  for trypsinized adrenal  tumor  cells.  There  were  no 
apparent  structural  differences  between  cells  isolated 
with enzymes and those isolated in buffer alone. 
All  experiments were  carried  out  using  tumor  cells 
isolated without enzymes, except in the case where cells 
isolated  with  and  without  enzymes  were  compared. 
Incubations of the isolated cells were always carried out 
in  KRBG containing 5 mg/ml  BSA.  Lima bean trypsin 
inhibitor  (I  mg/ml)  was  also  added  when  cells  were 
isolated with trypsin and collagenase.  Incubations were 
carried out in  10-ml beakers in a  final volume of 1.5 ml 
with shaking in a  Dubnoff metabolic incubator (60 rpm) 
at 37°C for 2 h under an atmosphere of 95% 02-5% CO~. 
ACTH  used  in  the  incubation  studies  was  USP 
corticotropin  reference standard  distributed  by  United 
States  Pharmacopeial  Convention,  Inc.  Dibutyryl  cy- 
clic-3', 5'-AMP (dbCAMP) and NADPH were obtained 
from Sigma Chemical Co., St.  Louis,  Mo.; trypsin and 
lima bean trypsin inhibitor from Worthington Biochemi- 
cal  Corp.,  Freehold,  N.  J.;  collagenase  from  Gallard- 
Schlesinger Chemical  Mfg. Corp.,  Carle  Place,  N.  Y.: 
and  bovine  serum  albumin  (BSA)  fraction  V  powder, 
Pentex, from Miles Laboratories Inc. Kankakee, 111. All 
other chemicals were  of reagent  grade  purity obtained 
from various sources. 
Steroid Measurement 
Corticosterone  was  measured  essentially  by  the 
method of Silber et al. (14).  Incubation sample aliquots 
and  corticosterone  standards  were  dissolved  in  13% 
EtOH  and extracted with 4 ml of methylene dichloride. 
After  removal  of  the  ethanolic  phase,  3  ml  of  80% 
aqueous H2SO4  were added to the methylene dichloride 
extract. After shaking, the fluorescence of the acid phase 
was measured on an Aminco-Bowman spectrophotofluo- 
rometer (American Instrument Co., Travenol Laborato- 
ries,  Inc., Silver Spring, Md.), 50  min after addition of 
the  acid.  Appropriate blank  values were subtracted for 
any interfering fluorescence contributed by pregnenolone 
or  I I~'-OH progesterone. 
Pooled  incubation  samples  were  also  measured  for 
DOC.  After the addition of radiolabeled DOC (<0.001 
/~g, specific activity, 40 Ci/mmol, New England Nuclear, 
Boston, Mass.) as a recovery standard, the samples were 
extracted  thoroughly  with  methylene  dichloride.  After 
evaporation  of  most  of  the  organic  solvent  under  a 
stream  of  N2,  the  concentrated  extracts  were  run  on 
paper chromatograms in  the Bush  Bz system (15).  The 
A4-3-ketosteroids  on  the  dried  chromatograms  were 
visualized  under  UV  lights  and  tentative  identification 
was  made  by  comparison  with  known  standards.  A 
narrow strip from each chromatogram was immersed in 
blue tetrazolium reagent (16) for the detection of steroids 
containing a-ketol-reducing side chains; i.e., corticoster- 
one and DOC.  If a blue spot corresponding to DOC was 
observed, the remaining area on the chromatogram was 
eluted with ethanol and DOC measured quantitatively by 
the blue tetrazolium assay (16). 
Oxygen  Uptake Studies 
Mitochondria  from  the  tumor  tissue  and  normal 
adrenal  were  isolated  by  a  procedure  described  previ- 
ously (17).  The one exception was that only four to eight 
passes  of a  loose-fitting pestle  of the  Potter-Elvehjem 
homogenizer  were  made  for  homogenization  of  the 
tissue.  Although  not  usually  done  for  preparing  mito- 
chondria from normal adrenals (17), this was necessary 
to  avoid  excessive  breakage  of the  apparently  fragile 
tumor  mitochondria.  Electron  microscope examination 
revealed isolated fractions rich in intact mitochondria in 
both  normal  and  tumor  preparations.  However,  there 
was  a  degree of breakdown  of the internal  matrix  and 
breaking  of the outer membrane in  some of the tumor 
mitochondria. Oxygen utilization of the incubated mito- 
chondria was measured polarographically using a vibrat- 
ing  microplatinum  electrode  in  conjunction  with  an 
Oxygraph, model KM (Gilson Medical Electronics, Inc., 
Middleton, Wis.) as previously described (18,  19). 
Pyruvate  and Lactate  Measurements 
Incubations  of  normal  and  tumor  cells  were  also 
carried  out  for  pyruvate  and  lactate  production.  The 
effect of ACTH  and  dbCAMP  were  investigated, and 
arsenite was used as a blocking agent for pyruvate-lactate 
utilization.  Pyruvate  and  lactate  were  measured  by 
following the oxidation-reduction of NADH/NAD t  at 
340  nm  with  lactate  dehydrogenase  as  previously  de- 
scribed (12, 20). 
RESULTS 
Ultrastructure 
NORMAL  ADRENAL  TISSUE:  The  zona  fas- 
ciculata  of  the  normal  adrenal  gland  showed 
ultrastructural  features  (Fig.  l)  identical to  those 
reported  by  others  (21-24).  The  mitochondria 
were numerous and closely packed within the cell. 
They were circular or oval in shape and contained 
packed vesicular cristae. Lipid droplets were abun- 
dant and distributed irregularly in almost all cells. 
An  agranular  endoplasmic  reticulum  and  free 
ribosomes  were  also  apparent  throughout  the 
cytoplasm. 
TUMOR  TISSUE:  The  ultrastructure  of  the 
adrenocortical carcinoma tissue is shown in Fig. 2. 
The most striking intracellular change from that of 
the normal adrenal involves the mitochondria. The 
number of mitochondria per cell in the tu~or  was 
noticeably less than that of normal fasciculata cells 
(25%  that  of mitochondria  from  normal  rat  adre- 
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mitochondria (M) with vesicular cristae, and the preponderance of smooth endoplasmic reticulum (SER). 
Other features of the cell include lipid droplets (L), dense bodies (DB), and numerous free ribosomes. Arrow 
identifies one of the many intramitochondrial inclusions. ×  10,000. 
nal, based on milligrams of protein/original tissue 
wet  weight)  2.  Many  of  the  mitochondria  were 
elongated  and  generally  showed  a  much  less  uni- 
form  shape.  However,  the  most  striking  change 
was  the  predominance  of  sparse,  lamella-sbaped 
cristae.  Many  of the tumor cells contained  round 
to  oval  vesicles,  each  possessing  an electron-lucid 
matrix.  In many cases these vesicles were so large 
and numerous that they occupied  almost all of the 
cytoplasmic space. Occasionally, the membrane of 
one  or  more  of  these  vesicles  was  seen  to  be 
continuous with the outer nuclear membrane. The 
endoplasmic  reticulum  of  the  tumor  cells  was 
dilated  and  often  granular,  and  free  ribosomes, 
often occurring  in clusters,  were  quite apparent. 
ADRENAL  TISSUE  FROM  TUMOR-BEARING 
ANIMAL:  The  zona  fasciculata  of the  atrophied 
adrenal  gland  from  the  tumor-bearing  animal 
showed  marked  ultrastructural  differences  from 
both  the  normal  adrenal  and  the  adrenocortical 
tumor (Fig. 3). The cells appeared smaller, and the 
nuclear to cytoplasmic ratio appeared to increase. 
The  nuclei  often  presented  an  irregular  appear- 
ance, in contrast to the generally oval nuclei of the 
tumor and normal adrenal  cells. 
The  mitochondria  of adrenal  cells from  tumor- 
bearing  rats  were  less  numerous  and  of  less 
uniform  shape  than  those  found  in  normal  fas- 
ciculata  cells.  Mitochondria  from  the  atrophied 
adrenals  had  lost  their  characteristic  vesicular 
cristae  and  developed  lamellar  cristae  similar  to 
those  in  tumor  mitochondria.  The  mitochondrial 
matrix was more dense and few intramitochondrial 
inclusions were  seen.  Further, many mitochondria 
appeared  to  be  associated  with  the  formation  of 
membranous whorls  within  the atrophied  adrenal 
cells.  The  smooth  endoplasmic  reticulum  of  the 
atrophied  adrenals  was  less  developed  than  in 
normal fasciculata cells.  Lipid droplets were pres- 
ent, and lysosome-like dense granules were numer- 
ous. The observations are not unlike those found in 
adrenocortical tissue from hypophysectomized an- 
imals (24). 
LONG-TERM  ACTH  TREATMENT:  The  in 
vitro  results  of  Ney  et  al.  (3)  on  corticosterone 
production by the adrenal from the tumor-bearing 
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and  possess lamellar  cristae.  Clusters of ribosomes and  rough endoplasmic reticulum fill the cytoplasm. 
Some cells are filled with large electron-lucid vacuoles (V}. ×  8,100. 
rat demonstrated that the decreased production of 
steroid  by  this  adrenal  returned  to  normal  levels 
after  pretreatment  with  ACTH.  To  study  any 
ultrastructural  changes  which  might  occur  after 
ACTH  administration,  we  injected  both  normal 
and tumor-bearing rats with ACTH over a period 
of 2  wk.  At  the  end  of the  treatment  period  the 
adrenals  of both groups were examined. 
The  changes  in  ultrastructure  of  the  normal 
adrenal observed between the control (Fig.  1) and 
ACTH-treated  (Fig.  4)  rats  in  this  study  are  in 
accordance with previous findings (25-27).  These 
include,  most noticeably, an  increase in  the num- 
ber  of  mitochondria,  lipid  droplets,  and  smooth 
endoplasmic  reticulum.  In  addition,  the  normal 
adrenal  glands  after  ACTH  treatment  had  in- 
creased to about five times their normal size. 
The change in the adrenal from the tumor-bear- 
ing animal was striking after ACTH (Fig. 5). The 
cells  appeared  to  regain  their  normal  size  and 
nuclear to cytoplasmic ratio. The nuclei presented 
a normal round to oval appearance. The mitochon- 
dria  were  of a  normal  shape  and  size,  and  they 
filled the cytoplasm. The mitochondrial cristae had 
regained their vesicular character.  The lipid drop- 
lets became noticeably larger, equal to those in the 
normal adrenal after ACTH treatment.  The adre- 
nals had  become greatly enlarged, the wet weight 
rising  from  approximately  8  mg/pair  before 
ACTH to about  100 mg/pair after the 2-wk period 
of injections. 
Steroidogenesis 
We found that the adrenocortical tumor can be 
dissociated  into  isolated  cells  without  the  use  of 
proteolytic enzymes.  This is a property not found 
in most other tissues,  and  it permitted a compari- 
son  of the  steroidogenic capacity of cells isolated 
with and without proteolytic enzymes. When incu- 
bated  with  various  steroid  precursors,  there  was 
little or no difference in the steroidogenesis of the 
cells regardless  of the  method  used  for isolation, 
indicating that the use of trypsin and other proteo- 
lytic  enzymes  is  unnecessary  in  the  case  of this 
adrenal tumor. 
Table  I shows the corticosterone production  by 
isolated  cells  from  the  normal  adrenal  and  the 
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smaller and  contain  fewer mitochondria  (M) than  normal  fasciculata cells. The  mitochondria  no longer 
exhibit vesicular cristae and are often seen associated with whorls of membranes (Wh). Small dense bodies 
(DB), probably lysosomes, are evident within these cells. × 8,100. 
adrenal  tumor.  As  noted  in  Materials  and 
Methods, normal cells were isolated using trypsin- 
collagenase, the  tumor  cells in  buffer alone.  The 
normal  adrenal  cells  synthesize  only  negligible 
amounts  of corticosterone in control incubations. 
This is in agreement with our previously published 
data  (20).  Addition  of ACTH or  dbCAMP  pro- 
duced  at  least  a  10-fold  increase  in  the  levels of 
corticosterone. The addition of corticosterone pre- 
cursors,  pregnenolone,  DOC,  and  liB-OH-pro- 
gesterone,  also led to  a  marked  increase in  corti- 
costerone  production.  Progesterone,  however, 
seemed to  be  utilized less readily than  other pre- 
cursors. 
Corticosterone  production  by  tumor  cells  was 
extremely low when  compared  to that  by normal 
cells.  Neither  ACTH  nor  dbCAMP  had  any 
stimulating effect on  the tumor cells. Among the 
corticosterone  precursors,  1  U3-OH-progesterone 
was utilized most efficiently followed by DOC and 
pregnenolone.  Progesterone  was  again  the  least 
efficient precursor.  It is clear from Table I that in 
the  tumor cells, corticosterone levels, after a  2-h 
incubation in the presence of DOC, progesterone, 
and  pregnenolone,  were  only  about  1.5-2.5%  of 
those in  normal ceils, whereas with  1  l~-OH-pro- 
gesterone, they were as much as  13%. 
The  results  described  above  suggested  that  a 
major defect in  the  steroidogenic pathway  in  the 
tumor  was  at  the  1 l/3-hydroxylation  step  which 
takes place in the mitochondria and is the last step 
in the conversion of DOC to corticosterone. If this 
were the case, DOC might be expected to accumu- 
late  when  the  tumor  cells  were  incubated  with 
pregnenolone or progesterone. Table II shows the 
qualitative results after chromatographic analysis 
of the incubation media after incubation with these 
steroids and other substances. Normal cells did not 
produce  detectable levels of corticosterone under 
control  conditions,  but  did  so  under  all  other 
conditions tested. DOC, however, was only quali- 
tatively detectable in chromatograms of samples to 
which  the  steroid  precursors,  pregnenolone  and 
progesterone,  had  been  added.  The  tumor  cells 
also showed detectable levels of DOC in chromato- 
graphed samples containing the steroid precursors, 
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the vesicular appearance of mitochondrial cristae. Lipid droplets (L) are numerous and generally larger than 
in nonstimulated adrenal fasciculata cells. × 8,100. 
but did not demonstrate any qualitatively detecta- 
ble  corticosterone  production  under  any  of  the 
other conditions tested.  The eluted  DOC  regions 
from the chromatograms with detectable levels of 
DOC were quantitatively assayed  by the blue-tet- 
razolium  procedure.  These  values  coupled  with 
corticosterone  levels  (quantitative)  provided  a 
DOC to corticosterone ratio (Table II). The ratios 
for the tumor cells were  15-25  times higher than 
those for the normal cells,  indicating a  significant 
build  up  of DOC  in  the  tumor  cells.  It must  be 
mentioned that actual levels of DOC were lower in 
the  tumor  cell  incubations  than  in  those  of  the 
normal  cell, indicating a  decreased production of 
DOC  or  its  increased  metabolism  by  a  pathway 
not leading to corticosterone. At present, however, 
we  have  been  unable  to  detect  any  other  A  4 
unconjugated  3-ketosteroid  besides  DOC  which 
might  be  a  metabolic  product  of the  tumor  cell 
incubations. 
OXYGEN  UPTAKE  STUDIES:  Isolated  mito- 
chondria  were  studied  for  their  ability  to  utilize 
oxygen  and  produce  corticosterone.  As  shown  in 
Fig. 6 A, the oxygraph trace obtained with adrenal 
mitochondria from normal,  nonstressed  rats (nor- 
mal mitochondria) was as expected when succinate 
was the oxidizable substrate (18,  28). A P/O ratio 
of about  1.9 was obtained after the addition of 200 
nmol of ADP, whereas 10.5 nmol ofcorticosterone 
were formed per minute per milligram mitochon- 
drial  protein  after  all exogenous  ADP  had  been 
utilized. Addition of 2,4-dinitrophenol (2,4- DNP) 
led to a large increase in oxygen uptake,  and as is 
usual, to an inhibition of corticosterone production 
brought  about  by  the  uncoupling  effect  of  this 
substance  (17).  The  picture  presented  by  tumor 
mitochondria incubated with succinate was similar 
in terms of 02 consumption as well as to the degree 
of coupling of oxidation with phosphorylation, as 
indicated  by a  P/O ratio of about two (Fig. 6  B). 
On the other hand, it is clear that after the addition 
of  DOC,  little  l l~3-hydroxylation  of this  steroid 
took  place.  What  little  corticosterone  synthesis 
occurred  with  DOC  was completely abolished  by 
the  addition of 2,4-DNP.  Although not  shown in 
the  figures,  addition  of  the  respiratory  chain 
inhibitors Antimycin A and KCN in similar exper- 
iments inhibited succinate-supported 02 uptake in 
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rat adrenocortical cells. Note vesicular  cristae of the mitochondria. ×  5,000. 
TABI.I~  1 
Corticosterone Levels in Cells Isolated from  the Normal Adrenal and Adrenal Tumor 
Additions  Normal  Tumor 
Control  1.01 ± 0.17 (8)*  0.07 ± 0.01 (8) 
ACTH 800 ~U/ml  11.99 :~ 1.20(8)  0.07 ± 0.01 (8) 
ACTH 1,600/aU/ml  13.56 ± 0.79 (8)  0.08 ± 0.01 (8) 
dbCamp 500 tam  13.98 ± 0.45 (8)  0.06 ± 0.01 (8) 
Pregnenolone 80 ttg/ml  36.64 ±  1.88 (8)  0.50 ± 0.05 (8) 
Progesterone 80#g/ml  7.14 ± 0.62 (8)  0.17 ± 0.01 (8) 
DOC 80ttg/ml  37.17 ±  1.55 (8)  0.61 ± 0.07 (8) 
1  I  B-OH-Progesterone  20 ttg/ml  37.08 ±  1.86 (7)  4.79 ± 0.18 (8) 
* Mean  ±  standard error (N). 
Either  1.5-2.3  x  105  (normal) or  1.0-1.5  ×  l0  s (tumor) cells per 
expressed as micrograms corticosterone/l0  s cells. 
beaker were  incubated 2 h at 37°C. Results are 
both the control and  tumor mitochondria. Corti- 
costerone production  was  also  completely inhib- 
ited  by  these  two  substances  in  the  control  and 
tumor mitochondria. 
Other  experiments carried out  with the  Krebs- 
cycle acids a-ketoglutarate, malate, and isocitrate 
showed  expected 02  uptake  rates  and  substrate- 
supported  steroid  l l~-hydroxylation of  DOC  in 
normal mitochondria (18, 29). On the other hand, 
little or no O2 uptake or corticosterone production 
was  observed  with  these  substrates  when  tumor 
mitochondria  were  incubated,  regardless  of 
whether P~ or ADP were added singly or together 
to  the  incubation  medium.  As  will  be  discussed 
later,  these observations could indicate a  relative 
paucity in the tumor of some flavoprotein enzymes 
in  both the respiratory chain and  the cytochrome 
P450 chain involved with steroid hydroxylations. 
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Qualitative Analysis of Pooled Samples for Steroid Production and their Resultant  DOC-to-Corticosterone 
Ratio 
Normal  Tumor 
B*  DOC  DOC:B  B*  DOC  DOC: B 
Control  -  -  - 
ACTH 1600 #U/ml  +  -  -  - 
dbCamp 500 #M  +  -  -  - 
Pregnenolone 80 #g/ml  +  +  0.4  -  +  10.7 
Progesterone 80 #g/ml  +  +  2.5  -  +  37.0 
Steroids separated by paper chromatography and analyzed with blue tetrazolium. 
* B, Corticosterone. 
+, visible spot;  -,  no visible spot after treatment with the blue tetrazolium reagent. 
A 
P2 
0  2:100  /  .~,.,,Succina  te 
32=9.7 ~,~ 
0  2:22.5 ~ADP 
Oz=4&8 
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02:22.5 "Xl~ 
"~=I0.5 
02=424 
~,4-DNP 
~B=34  02=9Z4~ 
02:C  215  5!0  7~5  ,01.0 
Time (min) 
B  r 
0  z =  lO0 L  ~'p2  ~cinote 
~002  =  295 ~B =  0.5 
c 
N~,4-DNP 
0 2 =419 
o  :o  2'.s  5'.0  7'.5  '  IO.O 
Time(min) 
FIGURE  6 A  and 6  B  Traces of O~ uptake measured polarographitcally at 37°C. The ordinate is a  relative 
scale and represents 199 nmol 02 in  1.00 ml buffer at 37°C. Approximately 0.70 mg mitochondrial protein 
was added to  1.00  ml buffer, pH  7.4, containing  14 mM Tris-HCl,  16  mM  KC1,  16 mM  NaC1,  55  mM 
nicotinamide, 250 mM sucrose, 1.5 mM inorganic phosphate (P~), and 0.15% bovine serum albumin (BSA) 
in final concentrations. 0.05 ml succinate (5 #moll 0.02 ml ADP (0.2 #mol  L 0.01 ml DOC (0.10 umol), and 
0.01 ml 2,4-DNP (0.05 #mol) were added as indicated above the traces by arrows. Corticosterone (B) and 02 
values above and  below the lines,  respectively, are the rates of corticosterone production and 02 utilized 
expressed as nmol/mg mitochondrial protein/rain incubation. Double arrows show points at which all ADP 
added has been utilized (38).  P~ indicates the addition of 0.10 ml of mitochondrial suspension. 6 A, control 
mitochondria; 6  B, tumor mitochondria. 
PYRUVATE  LACTATE  ACCUMULATION: 
Table  IIl  compares  the  glycolytic  response  of 
tumor  and  normal  adrenal  cells  to  ACTH  and 
dbCAM  P. The doses of the two stimulating agents 
used  are  known  to  be  maximally  stimulating  for 
normal  adrenal  cells  (12,  20).  Under  these condi- 
tions the increases in pyruvate and lactate accumu- 
lation  due  to  both  ACTH  and  dbCAMP  were 
much  smaller  in tumor  cells than  in  normal  cells. 
This could not have been due to increased metabo- 
lism  of  pyruvate  in  the  mitochondria  by  the 
enzyme  pyruvate  dehydrogenase,  because  in  the 
presence of arsenite (which inhibits pyruvate dehy- 
drogenase) the increases in pyruvate and lactate in 
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Effect of ACTH, dbCAMP, and Arsenic on Pyruvate  and Lactate Levels  in  Tumor and Normal Adrenal Cell 
Suspensions 
Normal  Tumor 
Additions  Pyruvate  Lactate  Pyruvate  Lactate 
None  52.1 ± 6.4  392.2 ±  18.9  37.7 ±  1.3  154.7 ±  10.7 
ACTH 2 mU/ml  152.6 ±  18.4  536.1 ± 56.2  54.9 ±  1.7  172.0 ± 5.0 
(100.5)  (143.9)  (19.2)  (17.3) 
dbCamp 500~zM  126.6 ±  12.0  534.8 ± 35.4  44.7 ±  1.3  179.3 ± 9.9 
(74.5)  (142.6)  (9.0)  (24.6) 
Arsenite 2.0 mM  220.9 ±  13.6  595.4 ±  11.2  88.2 :~ 1.8  234.2 ~  5.3 
(168.8)  (202.2)  (52.5)  (79.5) 
ACTH 2 mU/ml +  229.6 :~ 9.6  703.6 ±  17.2  83.1 ±  3.3  267.9 ±  11.2 
Arsenite 2 mM  (177.5)  (311.4)  (47.4)  (113.2) 
dbCAMP 0.5 mM +  248.2 ±  14.2  620.5 ± 7.6  86.7 ± 2.9  252.4 ±  17.6 
Arsenite 2 mM  (196.1)  (228.3)  (51.0)  (97.7) 
Each value expressed  as nM/10 e cells/2 h incubation time, is the mean ± SE (N = 4). Values in parenthesis denote the 
net increase  over the incubated control. The incubations were carried out for 2 h at 37°C under 95% O~-5% CO2, and 
pyruvate and lactate were measured on the total incubate;  i.e., cells  +  medium. 
the tumor cells were again much lower than those 
in the normal  adrenal cells. 
DISCUSSION 
In  the  normal  adrenal  gland  ACTH  stimulates 
membrane  adenyl  cyclase  which  promotes  the 
conversion of ATP to CAMP. This cyclic nucleo- 
tide,  in turn,  inceases the synthesis of corticoster- 
one by stimulating the conversion of cholesterol to 
pregnenolone  in  the  following  sequence:  choles- 
terol 1  pregnenolone  L  progesterone  3~ DOC 4 
corticosterone.  Reactions  nos.  1 and  4  are exclu- 
sively associated with the mitochondria in adrenal 
cells, whereas  reactions  nos.  2  and  3 occur in the 
cell  cytosol  and  microsomes,  respectively  (8,  9). 
This sequence is severely limited in the adrenocor- 
tical carcinoma 494  (1  5),  apparently  at a  step(s) 
beyond  the  formation  of  CAMP  (4).  It  is  also 
limited  in  the  adrenal  from  the  tumor-bearing 
animal (3). 
Ney et al. (3) showed that  the in vitro corticos- 
teroidogenesis of the adrenal from the tumor-bear- 
ing animal was stimulated by ACTH treatment. In 
the  present  study  long-term  ACTH  treatment 
restored  a  normal  ultrastructure  to  this  adrenal. 
These results suggest that the limited steroidogenic 
capacity of this gland is directly related to reduced 
circulating  levels  of  ACTH.  Such  a  reduction 
could be in response to a negative feedback of high 
circulating levels of corticosterone as reported  by 
Ney et al. (3) and also observed in our laboratory. 
Although  the  tumor  on  a  per cell basis  produces 
very  little  corticosterone,  apparently  the  great 
mass  of  the  tumor  tissue  can  produce  relatively 
high circulating levels of corticosterone. 
In  the  tumor  the  mitochondrial  ultrastructure 
was  markedly  altered  and  the  number  of  mito- 
chondria per cell in the tumorous tissue was seen~o 
be considerably lower than that normally found in 
adrenal  fasciculata  cells.  In  addition,  large  elec- 
tron-lucid vesicles were quite often present within 
the  cell.  While  the  mitochondrial  origin  of these 
was not determined, the vesicles share some of the 
characteristics  of the  aminoglutethamide-induced 
abnormal  mitochondria  reported  by Racela et  al. 
(30). 
In  light  of  the  altered  crista  structure  and 
reduced  corticosteroidogenesis of the tumor,  it is 
possible  that  the  vesicular  conformation  of  rat 
adrenocortical  mitochondrial cristae in  some way 
enhances  the  ability  of mitochondria  to  perform 
the  associated  steroidogenic conversion.  If this  is 
the  case,  then  the  lamellar  cristae  would  not 
provide  the  optimum  conditions  for  cholesterol 
side-chain  cleavage  and  the  l l/~-hydroxylation 
reactions.  In  the  tumor,  our  results  and  those  of 
others  (2,  31)  showed  that  this  latter  enzymatic 
conversion was severely limited. However, Sharma 
and  Brush  (31)  reported  that  the  cells  of  this 
adrenocortical  tumor  are  capable  of  converting 
cholesterol  to  DOC,  indicating  that  tumor  mito- 
chondria  possess  the  caiaacity  to  convert  choles- 
terol  to  pregnenolone.  If this  is  indeed  the case, 
then  it would certainly appear  that  the structural 
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associated  only  with  events  leading to  the  llB- 
hydroxylation of DOC to corticosterone, and not 
with the conversion of cholesterol to pregnenolone. 
Further studies on this question would provide a 
better understanding of tumor and mitochondrial 
function. 
The fact that in the tumor 21-hydroxylation of 
liB-OH-progesterone  to  corticosterone  was  al, 
tered to a much lesser extent than  1  lB-hydroxyla- 
tion  of  DOC  to  corticosterone  gives  additional 
evidence that the major defect in the adrenocorti- 
cal  carcinoma is  mitochondrial in origin because 
the  21-hydroxylase enzyme is associated with the 
microsomal component of the fasciculata cells (8). 
The lack  of corticosterone production from  pro- 
gesterone  via  liB-OH-progesterone  can  be  ex- 
plained by the fact that the conversion of proges- 
terone  to  liB-OH-progesterone is  dependent  on 
the mitochondrial 1 IB-hydroxylase system (32). 
The  oxygraph  studies  also  showed  the  tumor 
mitochondria to be grossly abnormal in terms of 
02  utilization as  a  result of oxidation of Krebs- 
cycle substrates like isocitrate, malate, and c~-keto- 
glutarate.  The  finding  that  succinate  was  effi- 
ciently oxidized and indeed led to efficient coupling 
of oxidation to  phosphorylation, makes it highly 
probable  that  these  mitochondria  have  a  full 
complement of su~cinate debydrogenase enzyme, 
coenzyme(s) Q, and cytochromes required for 02 
utilization and ATP production. The finding that 
the other above-mentioned Krebs-cycle substrates 
were not utilized for 1 IB-hydroxylation of DOC or 
Oz  uptake  suggests that the tumor mitochondria 
are  lacking in flavoprotein enzymes required for 
NADH and NADPH oxidation (respiratory chain 
NADH dehydrogenase and the NADPH dehydro- 
genase of the steroid hydroxylation chain). This is 
supported  by  the  fact  that  exogenous  NADPH 
additions did not lead to the usual conversion of 
DOC into corticosterone as seen in normal mito- 
chondria  (16).  On  the  other  hand,  we  cannot 
assume  at  the  moment that  the  respective mito- 
chondrial dehydrogenases responsible for substrate 
oxidation (e.g.,  malate dehydrogenase) are present 
or  were  functional in  the  tumor  mitochondria. 
Experiments are  being carried  out to  investigate 
these questions. 
Abnormal  metabolic  function  of  the  tumor 
tissue was also apparent by a lower activity of the 
Embden-Meyerhof pathway. This was manifested 
by a  lower production of lactate and pyruvate in 
the  incubated tumor cells  as compared with that 
found  in  normal adrenal cells.  Whereas  ACTH, 
dbCAMP, and arsenite additions led to the usual 
large accumulation of lactate and pyruvate (20) in 
the incubated normal cells,  stimulation of glycoly- 
sis  by  ACTH  and  dbCAMP  or  inhibition  of 
pyruvate oxidation by arsenite was much less in the 
tumor  cells.  As  mentioned above,  these  results 
suggest  an  abnormal  metabolic  function in  the 
tumor. However, we cannot categorically rule out 
that  the  decrease  in  Embden-Meyerhof pathway 
activity  (as  reflected  by  lowered  pyruvate  and 
lactate  production)  is  due  to  glycolysis  being 
channeled  through  other  pathways,  rather  than 
being  totally  blocked.  One  of  these  pathways 
would  involve the  conversion of glyceraldehyde- 
3-phosphate to glycerol-3-phosphate via dihydrox- 
yacetone phosphate.  Should g!ycerol-3-phosphate 
be one of the main products of glucose metabolism 
in the tumor tissue besides pyruvate (or lactate), it 
is  conceivable that  the  glycerophosphate  shuttle 
provides  a  mechanism for  transporting cytoplas- 
mic  reducing equivalents into the  mitochondria. 
The  product  of this  reaction,  reduced  FAD (the 
flavin coenzyme of mitochondrial glycerol-3-phos- 
phate dehydrogenase), could then be oxidized via 
CoQ  and  the  respiratory  chain  to  yield  ATP 
necessary  for  growth.  It  would  be  desirable  to 
know whether  ATP production in the tumor cell 
arises mainly as a result of glycolysis per se or via a 
mechanism utilizing the glycerophosphate shuttle. 
In  any  case,  unlike  the  virtual  absence  of  the 
cytosol  NAD-linked  glycerol-3-phosphate  dehy- 
drogenase  in  a  wide  variety  of  cancer  tissues 
(33  35), we have found a normal degree of activity 
of  NAD  as  well  as  a  very  high  activity of  the 
mitochondrial counterpart,  FAD-linked enzyme, 
in tumor cells  2.  Further experiments are  in pro- 
gress to test the  physiological significance of the 
above findings. 
In  conclusion,  it  is  clear  that  the  reduced 
corticosteroidogenesis of the Snell adrenocortical 
carcinoma  is,  at  least  in  part,  due  to  reduced 
mitochondrial function. This specifically involves a 
lowered capacity for  1  IB-hydroxylation and could 
possibly be linked to a lack of or reduction in the 
certain mitochondrial enzymes necessary for nor- 
mal oxidation. However, we do not wish to suggest 
that this is the only cellular function that could be 
altered in the tumor cell. A number of other steps 
2 F.  G.  P~ron, A.  Haksar,  M.  T.  Lin, D.  Kupfer, G. 
Kimmel, and W. Robidoux, Jr.  Manuscript in prepara- 
tion. 
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kinase  activation  [36]  or  intracellular  pooling  of 
steroid  precursors  and  products  [37]),  may  be 
involved. The relative importance of these steps in 
steroidogenesis will  be  realized  only  with  addi- 
tional  investigation into  the  function  of both  the 
normal and tumorous adrenal. 
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